Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0000819050-22-000142
Filing Date
2022-09-01
Accepted
2022-09-01 16:11:10
Documents
61
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A bbi-20220630.htm   iXBRL 10-Q/A 1338551
2 EX-3.1 a2022063010qaex31.htm EX-3.1 32021
3 EX-3.2 a2022063010qaex32.htm EX-3.2 107424
4 EX-31.1 a2022063010qaex311.htm EX-31.1 10122
5 EX-31.2 a2022063010qaex312.htm EX-31.2 9883
6 EX-32.1 a2022063010qaex321.htm EX-32.1 8958
12 bbi-20220630_g1.jpg GRAPHIC 191265
  Complete submission text file 0000819050-22-000142.txt   5838667

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bbi-20220630.xsd EX-101.SCH 40711
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bbi-20220630_cal.xml EX-101.CAL 33618
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bbi-20220630_def.xml EX-101.DEF 182079
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bbi-20220630_lab.xml EX-101.LAB 421148
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bbi-20220630_pre.xml EX-101.PRE 286080
55 EXTRACTED XBRL INSTANCE DOCUMENT bbi-20220630_htm.xml XML 677703
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Brickell Biotech, Inc. (Filer) CIK: 0000819050 (see all company filings)

EIN.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-21088 | Film No.: 221221078
SIC: 2836 Biological Products, (No Diagnostic Substances)